Scientific Publications

Search by Keyword(s)
Found 9 results

Filters: Author is Ramkissoon, SH  [Clear All Filters]

Search Results

  • Showing 1-9 of 9 Results
2016
MAPK activation and HRAS mutation identified in pituitary spindle cell oncocytoma.Miller, MB, Bi WL, Ramkissoon LA, Kang YJ, Abedalthagafi M., Knoff DS, Agarwalla PK, Wen PY, Reardon DA, Alexander BM, Laws ER Jr, Dunn IF, Beroukhim R., Ligon KL, and Ramkissoon SH Oncotarget, 2016/05/09, (2016) Read More / View Supplemental Materials
Abstract
Disseminated glioneuronal tumors occurring in childhood: treatment outcomes and BRAF alterations including V600E mutation.Dodgshun, AJ, SantaCruz N., Hwang J., Ramkissoon SH, Malkin H., Bergthold G., Manley P., Chi S., MacGregor D., Goumnerova L., Sullivan M., Ligon K., Beroukhim R., Herrington B., Kieran MW, Hansford JR, and Bandopadhayay P. Journal of neuro-oncology, 2016/03/19, (2016) Read More / View Supplemental Materials
Abstract
MYB-QKI rearrangements in angiocentric glioma drive tumorigenicity through a tripartite mechanism.Bandopadhayay, P., Ramkissoon LA, Jain P., Bergthold G., Wala J., Zeid R., Schumacher SE, Urbanski L., O'Rourke R., Gibson WJ, Pelton K., Ramkissoon SH, Han HJ, Zhu Y., Choudhari N., Silva A., Boucher K., Henn RE, Kang YJ, Knoff D., et al. Nature genetics, 2016/02/01, (2016) Read More / View Supplemental Materials
Abstract
Case Report: Next generation sequencing identifies a NAB2-STAT6 fusion in Glioblastoma.Diamandis, P., Ferrer-Luna R., Huang RY, Folkerth RD, Ligon AH, Wen PY, Beroukhim R., Ligon KL, and Ramkissoon SH Diagnostic pathology, 2016/01/27, Volume 11, Issue 1, p.13, (2016) Read More / View Supplemental Materials
Abstract
2015
Rapid Intraoperative Molecular Characterization of Glioma.Shankar, GM, Francis JM, Rinne ML, Ramkissoon SH, Huang FW, Venteicher AS, Akama-Garren EH, Kang YJ, Lelic N., Kim JC, Brown LE, Charbonneau SK, Golby AJ, Sekhar Pedamallu C., Hoang MP, Sullivan RJ, Cherniack AD, Garraway LA, Stemmer-Rachamimov A., Reardon DA, et al. JAMA oncology, 2015/05/14, (2015) Read More / View Supplemental Materials
Abstract
SHMT2 drives glioma cell survival in ischaemia but imposes a dependence on glycine clearance.Kim, D., Fiske BP, Birsoy K., Freinkman E., Kami K., Possemato RL, Chudnovsky Y., Pacold ME, Chen WW, Cantor JR, Shelton LM, Gui DY, Kwon M., Ramkissoon SH, Ligon KL, Kang SW, Snuderl M., Vander Heiden MG, and Sabatini DM Nature, 2015/04/16, Volume 520, Issue 7547, p.363-7, (2015) Read More / View Supplemental Materials
Abstract
Clinical implementation of integrated whole-genome copy number and mutation profiling for glioblastoma.Ramkissoon, SH, Bi WL, Schumacher SE, Ramkissoon LA, Haidar S., Knoff D., Dubuc A., Brown L., Burns M., Cryan JB, Abedalthagafi M., Kang YJ, Schultz N., Reardon DA, Lee EQ, Rinne ML, Norden AD, Nayak L., Ruland S., Doherty LM, et al. Neuro-oncology, 2015/03/09, (2015) Read More / View Supplemental Materials
Abstract
2014
Angiomatous meningiomas have a distinct genetic profile with multiple chromosomal polysomies including polysomy of chromosome 5.Abedalthagafi, MS, Merrill PH, Bi WL, Jones RT, Listewnik ML, Ramkissoon SH, Thorner AR, Dunn IF, Beroukhim R., Alexander BM, Brastianos PK, Francis JM, Folkerth RD, Ligon KL, Van Hummelen P., Ligon AH, and Santagata S. Oncotarget, 2014/09/25, (2014) Read More / View Supplemental Materials
Abstract
2013
Genomic analysis of diffuse pediatric low-grade gliomas identifies recurrent oncogenic truncating rearrangements in the transcription factor MYBL1.Ramkissoon, LA, Horowitz PM, Craig JM, Ramkissoon SH, Rich BE, Schumacher SE, McKenna A., Lawrence MS, Bergthold G., Brastianos PK, Tabak B., Ducar MD, Van Hummelen P., Macconaill LE, Pouissant-Young T., Cho YJ, Taha H., Mahmoud M., Bowers DC, Margraf L., et al. Proceedings of the National Academy of Sciences of the United States of America, 2013/05/14, Volume 110, Issue 20, p.8188-93, (2013) Read More / View Supplemental Materials
Abstract
  • Showing 1-9 of 9 Results